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Conclusion: ESBL-producing aminoglycosides resistant E. coli 
s t r a i n s  isolated h m  clinical specimens in our NICU are first such 
strains proven in Croatia and should be of great concern in NICU 
patients. 
Candida i nfedio ns 
ml Candidaemia: A Cause or Effect of Staph. 
Septicaem ia ! 
C. W a d ,  A. Sharma. Sir Ganga Ram Hospital, New Delhi, India 
Objectives: Staph. aureus and Candida septicaemia cases were pur- 
sued to evaluate their causal relationship to each other. 
Methods: 1255 blood cultures were studied, using BacT/Alert 
(Organon-Teknika) Blood Culture system. Isolation of Staph. aureus 
(SA), Coagulase Negative Staph. (CNS), Candida sp. (C) and muc- 
ture of organisms SA+C or C+SA were evaluated as per the above 
objective. 
Results. 
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CNS cases had or developed Candidaemia. 10113, SA+C cases 
started with Staph. aureus (6) or Candida (4) septicaemia and pro- 
gressed to SA+C or C+SA on follow up. 2/36 Candida cases, had 
mixed septicaemia other than Staph. aureus, like E. coli, Enterobder 
sp, etc. whereas 13/36 cases developed SA+C septicaemia. 
Conclusions: The above suggests a cause and effect relationship 
of Staph. aureus and Candida sp. infections probably by way of pro- 
ducing mutually beneficial chemotactic or p w t h  factors that need 
furcher study. 
Candida Sepsis in Patients with HIV Infection 
M. Tumbarello, E. Tacconelli, G. Morace, R. Cauda. Departments 4 
Infem.ous Diseaes and Microbioloa, Rome, Italy 
Objective: to evaluate the risk and prognostic factors of the sepsis 
due to Werent species (spp.) of Candida in H N  infected patients 
admitted at OUT ward h m  1989 to 1996. 
Methods: a case control study was performed. A control p u p  of 
64 patients with AIDS and without sepsis was included in the study 
Results: we observed 32 H N  infected patients (the large major- 
ity of them were males, intravenous drug abusers and with AIDS) 
with Candida spp. sepsis. The isolated strains were C. albicans in 18 
episodes. (eps., 56%), C. tropicalis in 4 eps. (13%). C. glabrata in 3 
eps. (9%)). C. parapsilosis, C. h s d  and C. guillimnondii in 2 eps (6%), 
respectively and C. zeylanoides in 1 eps. Univariate analysis of predis- 
posing factors indicated that the low CD4+ T cell level t100/mmc 
(P = 0.02), the CVC usage (P = 0.02) and the neutropenia (neu- 
tmphils count <lOOO/mmc) (P = 0.04) were risk factors associated 
with the development of Candida sepsis. The response to therapy 
was favourable in 22 eps. (69%); death occurred in 10 eps. (31%). 
while a recurrence occurred in only 1 eps. The outcome of sepsis 
was influenced by the low number of CD4+ T cell (P = 0.01) and 
of neutmphils (P = 0.03). 
Conclusions: our data suggest that Candida sepsis is an important 
event in HIV-infected patients, especially under particular condi- 
tions (e.g. CVC usage, neutropenia and low CD4+ T cell level) and 
it requires a special attention h m  the physicians who must early 
recognise and treat this condition. 
w1 Candidemia: A Retrospective Study 
A. Garcia-Zabarte, M. Trevhio, C. Garcia-Kestra, M.D. Peiialver, 
A. Aguilera, B.J. Regueiro. Uniwnify Hospital Complu oJSanfiazo, 
Spain 
Objective: To evaluate, retrospectively, bloodstream episodes of 
Candida spp. along one year (1.995). 
Methods: Hemocultures were incubated in Bact Alert System. 
Positive samples were subcultured in Saboureaud agar (Biomerieux) 
and yeast isolates were identified by Vitek System (Biomerieux). C. 
parapsilopsis antdingal susceptibilities were assayed by E-test. 
Results: Total number of candidemias along 1.995 was twenty- 
five belonging to twentythree hospitalized patients. The yeast more 
ofienly isolated was C. parapsilopsis (52%) followed by C. albicans 
(32%). Other Cnndida species found were C. tropicalis, C. glabrata and 
C. lusitaniae. Fungemia by C. parapsilopsis was sigmficatively associ- 
ated to tumoral and pebtric patients (36% and 44%, respectively). 
We have not found any association between candidemia and age of 
patients. 
All C. parapsilopsis strains were sensitive to ketoconazole, flu- 
conazole, itmconazole, amphotericine B and flucitosine (MIC 90 
1 mcg/mL.). 
(1) G. parapsilopsis has just emerged as an important nosocomial 
(2) The prevalent yeast isolated firom fungal blood infections is C. 
(3) C. parapsilopsis strains isolated h m  hospitalzed patients are sen- 
Conclusions: 
pathogen in our hospital. 
parapsilopsis. 
sitive to the main systemic antifungal drugs. 
Candida spp. an important Pathogens in 
Nosocomial infections 
A. Samet, E. Czarniak. Deparfment 4 Clinical Bodm'olo~,  State 
Clinical Hospital W 1 in Gdansk, Poland 
Objectives: The aim of this study was to determine the influence of 
intensified antimicrobial therapy and intensive care measures on the 
incidence of Candida spp. isolated h m  different clinical specimens. 
Methods: We analysed 77 872 records of our dinscal mimbiol- 
ogy laboratory firom 1.1.1994 to 31.12.1995. 
Results: The incidence of Candida spp. in dinscal materials was 
higher about 36% in 1995 than 1994. Candida spp was the third 
most common organism recovered 6um the blood cultures in 1995, 
much increase comparing 1994 (the seventh place). Gandida albicans 
is still the predominant pathogen among the genus Gandida in our 
hospital. Two hospital units: ICU and Haematological Department 
had the most sigruficant increase in the incidence of Candih spp. 
Interestingly, in 1995 we observed a high increase in the incidence 
of Candida (Torulopsis) glabrata recovered 6um Merent dinical spec- 
imens. Candida (Torulopsis) glabrata represented 9% of all yeast isolates 
therefore special atcention should be paid to the treatment of fun- 
gal infections in our hospital (this species is kequently resistant to 
fluconazol). T h  increase is probably associated with a broad use of 
fluconazol in prophylaxis and empirical treatment of fungal mfec- 
tions in OUI hospital. 
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Conclusions: Our data indicate that patients in our hospital (es- 
pecially those severely compromised) are at high risk of candidiasis. 
I P I  234 I Nosocomial Breakthrough Fungemia During 
K. Kral'ovitovi, V Krcmery Jr., E. Oravcova, S. Spanik, 
M. Mrazow-Studena, J. Trupl, A. Kunova, A. Demitroviiovi. 
University .f Trnava, Trnava, Slovakia, Postgrad. Medical School, 
Slovakia, National Cancer Institute, Slovakia, St. Elizabeth's Cancer 
Institute, Slovakia 
The aim of the study was to investigate etiology, risk factors, antifun- 
gal prophylaxis and empiric therapy and outcome of 34 breakthrough 
fungemias in neutropenic cancer patients 
Three fungemias appearing during prophylaxis with fluconazole 
(Torulopsis glabrata, Hansenula anomala, Candida (C.) parapsilosis), 8 
with itraconazole (Trichosporon (T) pullulans - 3, T beigelii, C r  lauren- 
tii - 2, C. albicans, C. krusei), 10 with ketoconazole (C. noruegiensis, 
C. albicans - 7, C. stellatoidea, C r  laurentii, ?: pullulans), and 12 dur- 
ing empiric therapy with amphotericin B (C. albicans, C r  laurentii, 
Fusarium spp.). Most fiequent risk factors for breakthrough fungemia 
were neutropenia, therapy with multiple antibiotics, catheter inser- 
tion and hematologic malignancy. Comparing breakthrough with 
non-breakthrough fungemias, appearing at the same department in 
the same period, Merence in certain risk factors was noted break- 
through fungemias were more kquently observed in patients with 
mucositis after prophylaxis with quinolones (66.6% vs 16.7%, P < 
0.02) and were catheter-associated (29.4% vs 12.5% in the control 
group, P < 0.04). 
Antifungal Prophylaxis 
I PI 235 I Nosocomial Candida Colonization-Infections 
(Cl) in a Teaching Hospital: Epidemiology, Risk 
Factors, M o t t a l i  & Microbiology 
E G6ngora-Rubio ' , M.I.C.E. Maia ', L.E. Moreira ' , 
M.T.G. Almeida', D.VN. G6ngora'. 'Hospital de Base, SZo Josi do 
Rio Preto, Siio Paulo, Brazil, 'Institute Ado& h t z ,  Sio  Josh do Rio 
Preto, SZo Paula, Brazil 
Objectives: To determine the frequency and evaluate epidemiolog- 
ical, clinical, risk factors, mortality and microbiological features for 
Candida CI in a teaching hospital. 
Methods: All patients who had hospital acquired Positive Cul- 
tures (PC) for Candida species, at Hospital de Base, 450-bed general 
hospital, were prospectively studied during 1995 period. The iso- 
lates were identified by classic methods. Variables were analysed by 
univariate analysis with the Xz or Fischer's exact test. 
Results: During study period were identified 102 patients with 
118 PC, representing 3.36 per 1000 adrmssions. The facility with 
highest number of PC was the general ICU 34/118 (28.8%). The 
materials were: urine 0 42, blood (B) 24, catheter (C) 20 and 
others 32. U was associated with patients >60 years old and Foley 
catheterization, (P < 0.05 and P < 0.0001) respectively and C with 
TPN (P -= 0.01). B was associated with pehatric ICU (P = 0.02) 
and was not associated with TPN, neutropenia and central intram- 
cular catheter (CIC) (P > 0.05). Overall mortality was 37.3%. Of 
these total 38 deaths, 20 (52.63%) were in patients >60 years old (P 
= 0.05) and 24 (63.2%) were in ICUs, ofwhich 18/24 (75%) were in 
the general ICU (P < 0.01). Fdiy percent of isolates could be eval- 
uated. Candida albicans (Ca) was the most kquently isolated species 
(66.1%), followed by C. fropiralis (Ct) (25.4%), Toluropsisglabrata (Tg) 
(5.1%) and C. parapsilosis (3.4%). Ct was associated with pediatric 
and neonatal ICUs (P < 0.05), as well as Ca with CIC and Tg with 
TPN (P < 0.01). 
Conclusions: Age, critically ill patients, urinary catheterization, 
TPN and CIC were sigtllficant factors for Candida CI. Age and 
ICUs were associated with mortality. Ca was the most fiequently 
isolated species. Important efforts should be done to prevent and 
control these CI in these populations and units. 
1 PI 236 I Nasal and oral fungal colonization in renal 
transplat patients 
A.M. Dzamic, S. Mitrovic, V Arsic, 2. Dzamic, J. Hadzi Djokic, 
I. Knnjcic-Zec. YU 
No abstract available 
m1 No Evidence of Improved Toxicity of 
Amphotericin B in Intralipid: Results of a 
Confirmatory Randomized Phase Il-Trial 
P. Schofliki, M. Freund, R. Wunder, D. Petersen, A. Ganser. 
Hannover Medical School and University of Rostock, Germany 
Objectives: The use of Amphotericin B (AmB) for treatment of 
systemic mycosis is limited by a variety of toxicities (renal failure, 
K+ loss, fever, c w ) .  Other groups have used AmB in Intralipid 
20%, reporting an improved toxicity profile compared to conven- 
tional AmB in Dextrose in neutropenic pts. with fever of unknown 
origin (FUO) and HIV infection. We reevaluated the toxicity of this 
formulation. 
Methods: 51 neumpenic pts. (leukemia 35, lymphoma 11, solid 
tumors 5) with antibiotic-rehctory FUO (n = 24) or pneumonia 
(n = 27) were stratifed according to the underlying disease and ran- 
domized to receive AmB 0.75 mg/kg/d either in Dextrose 5% (n = 
24) or in Intralipid 20% (n = 27) as 1 h i.v. infusion. Concomitant 
treatment induded broad specmum antibiotics (n = 51) and 5-flucy- 
tosine (n = 36). Systemic therapy with AmB within 7 d prior study 
entry was prohibited. 
Results: At basehe, the study arm were balanced for age, sex, 
malignancy, state of infection, probability of systemic mycotic &ease 
(standardized evaluation), renal and liver function, pre- and con- 
comitant treatment with antibiotics or nephrotoxic agents. When 
comparing the study arm, no signhcant Merences (p < 0.05) 
were found during the course of treatment for any of the follow- 
ing endpoints: *Daily or cumulative dose and duration of AmB, 
*Incidence and time of dose modifications or infusion duration 
changes for AmB due to toxicity, *Dose or duration of symptomatic 
support with opiates, steroids, antipyretics, anahlstaminics, *Renal 
function (BUN, creatinine, crea. clearance), OK+ loss, Na++ and K* 
supplementation, *Hemoglobin, hematocrit, *Course of infection, 
*Incidence of treatment failures, *Physician's NCI toxicity ratings 
except sieuficant GOT increases in the Dextrose arm, opts. subjec- 
tive toxicity ratings except sigdicant, clinically relevant pulmonary 
toxicities in the Intdpid arm. 
Conclusions: At this dose and schedule, the use of Intralipid 
does not reduce toxicities related to AmB, but can be associated 
with severe, reversible pulmonary side effects, possibly due to fat 
embolism or a chemical instability of the drug combination. 
)p1238] ltraconazol versus Fluconazol in the Treatment 
of Oropharyngeal CandidiasisIComparing 
Study/ 
L. skodovi, M. Stankovski, A. S t r e k v i .  Dept. . f h z  Diseases, 
University of T m v a ,  Slovakia 
One hundred eleven mycologically proven oropharyngeal candidiasis 
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were included in to the randomised study to compare the efficacy of 
Itraconazol/Itr 53 patientdversus Flukonazol/Flu 58 patients/. All 
patients had neoplastic disease. Xsk factors such as radiotherapy, an- 
tineopkstic chemotherapy, used steroids, neutropenia, antimicrobial 
therapy and advance of cancer were recorded. Proportion of par- 
ticular pathogens did not show much Merences in both groups, 
especially C. albicans caused 56.6% of patients treated with Itr versus 
53.4% of those treated with Flu, non-albicans Candida spp. 36.9% 
in the group treated with Itr versus 41% Flu a T. glabrata a Tri- 
chosporon 7.6% versus 5.6%. Both regimens were well tolerated. 
Clinical response was documented in 92.5% of those treated with 
Itk and 96.5% treated with Flu at day 7 of therapy. Mycological 
eradication was documented on 7 day, and 10 in 64.2% versus 70.1% 
of patients. 
I PI 239 I Correlation of “In Vim” Susceptibility Testing 
with Epidemiology and lnmunosupression 
Level in AIDS Patients with Ompharyngeal 
Candidiasis 
M.J. GutiCrrez, R. San Millin’, A.I. AUer, M.A. Martinez, 
S. Bernal, M. Chivez, E. Martin Mazuelos. Servicio Minobiologia, 
H. U Wme, Sevilla, Spain, ’Depto. Minobiologia, UPV, Bilbao, Spain 
Objective: To study the Candida albicans epidemiology and the 
“in vitro” susceptibility associated recurrent oral candidiasis in 
HIV-infected patients treated with fluconazole (F) and the corre- 
lationship with the inmunosupression level (CD4 cells count). 
Material and Methods: 43 strains of C. albicans isolated h m  
oral swabs taken &om 15 HIV-infected patients with recurrent oral 
candidiasis attendmg the clinics of Valme Hospital (Sevilla) h m  
1993 to 1995 during 14 months. Oral swabs were plated onto 
Sabouraud glucose agar (Difco, USA) and isolates were identified 
by conventional mycological methods. Typing methods employed 
were: Serotyping (monoclonal antibody B9 for C. albirans serotype 
A); Morphotyping on malt extract agar (MEA) and on Sabouraud 
tripheni-tetrazolium agar (STTZ); Resistotyping to 5 fluorocyto- 
sine (F), boric acid (B); Tolerance to sodium chloride (SC), urea 0, 
and citrate assirmlation (C) and growth on MacConkey agar (MC); 
Enzimotyping (APY-ZYM, bioMerieux,). ”In vim” antdungal sus- 
ceptibility testing to F (Pfizer, UK), and itraconazole (I) (Janssen, 
Belgium) was tested by a Microdilution Method with RPMI 1640 
+ 2% glucose + MOPS (NCCLS). Breakpoint F 8 mg/l; arbitrary 
breakpoint I: 1 mg/l. These dates were correlated with the immuno- 
supression level (CD4 cells count). 
Results and Conclusions: 1. Serotype A was observed in 90.2% 
of C. albicam isolates. Two patients initially infected by C. albicans 
serotype B, yielded serotype A isolates. In these patients was ob- 
served an increment of MICs values to F (9 dilutions). 2. A change 
in susceptibility to F was observed in 10 patients (67%), 7 isolates 
(70%) showed higher MICs values (4-9 dilutions). Four of them 
showed a change in the morphotype, 4 in the enzimotyping and 2 
in both 4. The morphotype more kequent on MEA, was the 752 
(WCF) (23%), and on STTZ, W 2 Y  and W2N. 5. Resistotype did 
not showed any relation with morphotype and antifungal suscepti- 
bility pattern. 6. The C was the perfile enzymatic more fiequent 
(22/43), following B (10/43) and A (8/43). 7. The majority patients 
had low cells counts (CD4 t 220  mm). We observed a low corre- 
lation between the inmmumosupression level, the epidemiological 
markers and the antifungal susceptibility. 8. Two isolates with low 
susceptibility to fluconazole had a decreased susceptibility to I. 
-1 Candidiasis Esophagic and Antiacid Therapy 
A. Chocarro, A. Gonzalez, E Galindo, E Rueda, M. Chmeno, 
C. Villafaiie, E Alvarez, M.L. Iglesias. Hospital Virgen de La Concha, 
Zamora, Spain 
Objective: To know the incidence of candidiasis esophag~c (CE) in 
patients negative-HIV and the relation between the type of antacids 
and the development of CE. 
Methods: Retrospective study cases-control of the CE observed 
in our center between 1991-1995 (5-years) in patients negative HIV. 
The CE was defined with endoscopic and histologic criteria. For the 
controls were employed the previous and subsequent patient to each 
case. 
Results: They were found 37 patient with CE, represents 0.36% 
of the all gastroscopies. C. albicans was cultured in all specimens. The 
previous treatment with antacids were accompanied of a risk of CE 
of 5.11 (2.18-11.96). In the multivariate analysis was proven that 
Omeprazol was presenting a risk of 216 (p = 0.0033), the anti-H2 
of 5 (p = 0.12) and the alkaline of 1.11 (p = 0.94). Other factors 
that were related to the development of CE were: antibiotic therapy, 
cancer, steroids and digestive surgery. 
Conclusions: The antacid therapy probably prejudices to the 
development of CE. The risk is related to the power of the antacid, 
being greater for the Omeprazol. 
I PI241 I Cost Effectiveness of Oral Fluconazole for 
Three Days in Treatment of Uncomplicated 
Candiduna 
C.H. M e z - R o n d a ,  G. G o d e z ,  W Torres, G.A. Martinez. Son 
Juan VAMC - University ofl’uuerto Rim School $Medicine - SunJuan, 
Puerto Rim 
Purpose: To compare the effectiveness and safety of oral ~ ~ U C O M -  
zole (OF) with amphotericin B either in irrigation (AMBI) or as 
single dose (AMBSD) in the treatment of hospitalized patients with 
uncomplicated candiduria. 
Methods: All patients seen over a 16 months period between July 
95-October 1996 with a urinalysis positive for Candida were candi- 
dates for the study Patients without systemic sings of mfection were 
included. Every patients underwent a repeated catheterized urinaly- 
sis and culture. Patients with confirmed candiduria were mdomized 
to one of 3 treatment regimes AMBSD 0.3 mg/kg to run IV in 16 
hrs, AMBI 10 mg/L runing at a rate of 41 cc/hr/day for 3 days via 
triple lumen catheter or OF 200 mg first day then 100 mg daily for 
2 days. Patients were checked daily and repeated catheterized urinal- 
ysis were done immediately post therapy, 5 days post starting therapy 
and 2 and 6 weeks after therapy. 
Result A total of 365 pts were screened and 115 randomized. 
Reasons for exclusion were negative catheterized urine in 125 (34%). 
60 (16%) had a likely systemic illness. Pa that completed therapy 
were 100/115, 30 in AMBSD, 32 in AMBI and 38 in OE The as- 
sociated conditions in the 3 groups were comparable. Clinical cure 
defined by lack of symptoms was absolute in all 3 treatment regimes, 
bacteriologic enadication in 90% AMBSD, 81% AMBI and 100% 
O E  The bacteriologic erradication persisted >6  weeks post Rx. 
The most fiequent pathogen was Candida tropicalis (84 strains) and 
Candida albicans (34 strains). None of the strains developed resis- 
tance. 
Conclusion: For the management of uncomplicated candiduria, 
any of the 3 treatment regimes was comparable in dectiveness, OF 
erradication was 100%. It is important to note that 34% of the 
patients with candiduria in a routine urinalysis had no evidence of 
candiduria on a repeated catherized urine. 
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lp1242] Monitoring of Efficiency Antifungal of Therapy 
on Gazchromatographic Markers of Fungi at 
the Children 
VA. Kurchavov, E.L. Rogatina, N.B. Boyko. Moscow Pediatric Center 
ofhboratoty Diagnostic, Pediatric Filatou Hospital, Moscow, Russia 
Systemic fungal lnfection at the children of high risk are 
not always accompanied by isolation Candida spp. ftom blood. 
Gaz-chromatograph detection some metabolites of Candida 
(D-arabinitol and mannoza) in serum blood and/or cerebrospinal 
fluid could be used as method for presumptive diagnosis and mon- 
itoring of fungal meningitis due to Cundida spp Thirty patients, 
h m  7 days ull5 years old with suspect fungal meningitis have been 
studied. Before treatment we have carried out chromatographic ex- 
amination of fungi's metabolites (D-arabinitol, mannoza) in serum of 
blood and cerebrospinal fluid. All patients had the level of metabo- 
lites higher than normal levels @ -= 0.001). 
All patients have been carried out andfungal therapy by flucona- 
zole in dosage 10-12 mg/kg once a day. After the course of ef- 
fective andfungal therapy the level of metabolites was decreased to 
norm. @ c 0,001). Increase or the preservation of increased level 
D-arabinitol in cerebrospinal fluid (4 supervision) coincided with 
clinical attributes non effective of therapy and required replacement 
fluconazole on amphotericin B. 
Fungal infections II 
PI243 I The Rate of Isolation of Candida species from 
V Stroganov, T. Mityushkma, V Makarova, M. Romanova. Clinical 
Microbiology Lboratory, Sperarvky Children's Hospital, Moscow, Russia 
Objectives: To determine the rate of isolation of Werent Candida 
species h m  pediatric burn patients. 
Methods: 112 Candida species were isolated h m  62 patients be- 
tween April 1996 and December 1996.73 strains were isolated ftom 
wounds, 28 h m  throat, 6 ftom urine and 5 from blood. Identifi- 
cation of Candida was performed with Mycotube-system (Becton 
Dickmson, Cockeysville, MD). 
Results: The percent of isolation of Merent species of Can&& 
from burn wounds was the following: Candida albicans - 49.3% (36 
strains) ,  Candida stellatoidea - 16.4% (12 strains), Candida krusei - 
16.4% (12 strains), Candida fropicalk - 11% (8 saa ins) .  
Candida albiram was the yeast most frequently isolated &om throat 
- 67.9% (19 s t r a i n s )  and urine - 5 strains kom 6. 
Five cases of fungemia were caused by Candida tropicalis (3 strains), 
Candida pseudotronicalis (1 strain) and Candida albicans (1 strain). 
Conclusions: In our study Candida albicarv was the yeast most 
frequently isolated &om burn wounds, throat and urine. The major- 
ity of cases of fungemia were caused by Candida fropicalk. 
Pediatric Bum Patients 
[p12441 Comparison between the Species of Candidas 
Isolated in Vaginitis during 5 Years and the 
Isolated in Recurrent Vaginitis for Candida 
M.A. Blanco, E Salazar, 0. Gomez, E Izquierdo. H . U  Santa 
Criztina, Madrid, Spain 
Objectives: Know if in our population, there is Werences between 
the species isolated in recurrent vaginitis for candida concerning the 
patients with no-recurrent vaginitis. 
Methods: We have studied 4327 vag7.d exudate, between the 
years 1992 and 1996, where they have been diagnosed 1135 Can- 
didas. The idenafication to level of species was carried out with 
the system ID32C-ATB (bioMCrieux). Continuing the literature, 
we considered recurrent vaginitis for candida, those that has had 
episodes of vaginitis, at least 4 times in 1 year. 
Results: In 1135 (26.2%), of the 4327 studied patients, Candida 
spp was isolated. The frequency accordmg to the species was: C. 
albicans 55%, C. glabatra 10.7%, C sake 4.2%, C. parapsilosis 1.4%, 
C. tropicalis 1.05%, C. krusei 0.8%, another 26.6%. The dmribution 
per years was the following; in the year 1992: C. albicans 71%, C. 
glabatra 6.72%, C. parapsilosis 4.49%. C. sake 1.12%, another 16.7%; 
in the year 1993: C. albicans SO%, C. glabatra 14%, C.  krusei 2.5%, 
C. sake 0%, another 33.5%. in the year 1994: C. albicans 57%. 
C. glabrata 11.4%. C. krusei 3.2%, C. sake 0%, another 28.4%; in 
the year 1995: C. albicans 57%, C. glabrata 11.5%, C. sake 3.23%, 
another 28.3%; in the year 1996: C. albicans 50%, C. glabrata lo%, 
C. sake 7%, another 33%. During the years 1994, 1995 and 1996, 
there was 971 vaginitis for cankda, which 188 (19.3%) they were 
recurrent vaginitis; the distribution for species was the following: 
C. albicans 67.5%, C. glabrata 22.3%, C. sake 4.2%, C. parapsilosis 
3.19%, C. tropicah 1.5%, another 1.06%. 
Conclusions: C. albicans was the specie more fkequently isolated 
in all laud years, so much in recurrent vaginitis like not recurrent, 
followed by C. glabrata. There are not significant Werences between 
the species of candida granted asylum in recurrent vaginitis and not 
recurrent. We highhghted the increase of the frequency of C. sake 
that took place in recurrent vaginitis like not recurrent. 
Wl Microbiological Features of AIDS-Associated 
Cryptococcosis (C), and Their Relationship 
with Clinical Course of Disease 
R.  Manfredi ' , A. Mazzoni 2 ,  A. Nanetti 2 ,  A. Moroni 2,  
M. Donati ', A. Mastroianni ', 0. Coronado 
'Department $Experimental and Clinical Medicine, Division of Infeaious 
Diseases, 'Department of Experimental and Cliniral Medicine, Division of 
Microbidon, University of Bologna, Bologna, Italy 
Objective: To assess diagnostic techniques of AIDS-related C, with 
regard to clinical course and outcome of disease. 
Methods and Results: HIV-infected patients @) with a CD4+ 
count <100/,uL and suspected C were screened by associated culture 
(ofblood, CSF, urine or tissues), direct CSF microscopy, histopatho- 
logic examination of biopsy specimens, and search for the polysac- 
charide antigen in serum or CSF: 43 consecutive cases of C were 
identified (12 with CNS involvement, 2 with sepsis, and 29 with 
associated meningoencephalitis and sepsis). In the setting of CNS C, 
antigen detection was the most sensitive method (93.9%), followed 
by microscopy (83.7%), and culture (81.4%): in 4 p C was disclosed 
initially by the detection of isolated CSF antigen. Thuty-one p out 
of 43 suffered horn disse-ted C, with positive blood cultures 
and/or antigenemia. In 7 p out of 43 (16.3%) cutaneous involve- 
ment was present since disease onset, and related to a rapidly fatal 
course (< lo  weeks). All p received systemic andfungals, and those 
obtaining c h c a l  remission underwent suppressive antimycotic ther- 
apy. During the subsequent follow-up (10-118 weeks), 25 p went 
to death after 25.6 f 28.1 weeks, in presence of C (as shown by 
microbiological and autopsy studies). The occurrence of death and 
the overall survival did not show differences between p with isolated 
CNS C and p with associated fungemia, while sepsis and skin local- 
ization were sipficantly related to a rapidly lethal course (p < 0.05, 
x2 test). Sixteen p out of 29 who obtained clinical remission (55.2%) 
experienced one or more relapses despite secondary chemoprophy- 
laxis; the fkquency of relapses and the time to their occurrence did 
E Chiodo '. 
